Nature of the neurotoxic membrane actions of amyloid-β on hippocampal neurons in Alzheimer's disease

Neurobiology of Aging

Volumn 35, Issue 3, 2014, Pages 472-481

  Sepúlveda, Fernando J ^a   Fierro, Humberto ^a   Fernandez, Eduardo ^a   Castillo, Carolina ^a   Peoples, Robert W ^b   Opazo, Carlos ^a   Aguayo, Luis G ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b MARQUETTE UNIVERSITY   (United States)

Author keywords

A ; A toxicity; Alzheimer's disease; Membrane disruption; Pore formation

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM ION; CELL PROTEIN; GRAMICIDIN; PEPTIDE; SYNAPTIC PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; HIPPOCAMPUS; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; NERVE CELL MEMBRANE; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEPLETION; PROTEIN FUNCTION; RAT; SYNAPTOTOXICITY;

ALZHEIMER'S DISEASE; AΒ; AΒ TOXICITY; MEMBRANE DISRUPTION; PORE FORMATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CALCIUM; CALCIUM SIGNALING; CELL MEMBRANE; GRAMICIDIN; HEK293 CELLS; HIPPOCAMPUS; HUMANS; MEMBRANE POTENTIALS; MICROSCOPY, ELECTRON, SCANNING TRANSMISSION; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84889590775     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.08.035     Document Type: Article

References (24)

1. Aguayo L.G., Parodi J., Sepúlveda F.J., Opazo C. Pore-forming neurotoxin-like mechanism for Abeta oligomer-induced synaptic failure. Current Hypotheses and Research Milestones in Alzheimer's Disease 2009, 13-21. Springer, New York. G. Perry, R.B. Maccioni (Eds.).
2. Akaike N. Gramicidin perforated patch recording and intracellular chloride activity in excitable cells. Prog. Biophys. Mol. Biol. 1996, 65:251-264.
3. Andersen O.S. Ion movement through gramicidin A channels. Interfacial polarization effects on single-channel current measurements. Biophys. J. 1983, 41:135-146.
4. Arispe N., Pollard H.B., Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. U.S.A 1993, 90:10573-10577.
5. Arispe N., Rojas E., Pollard H.B. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. U.S.A 1993, 90:567-571.
6. Capone R., Quiroz F.G., Prangkio P., Saluja I., Sauer A.M., Bautista M.R., Turner R.S., Yang J., Mayer M. Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy. Neurotox. Res. 2009, 16:1-13.
7. Diaz J.C., Simakova O., Jacobson K.A., Arispe N., Pollard H.B. Small molecule blockers of the Alzheimer Abeta calcium channel potently protect neurons from Abeta cytotoxicity. Proc. Natl. Acad. Sci. U.S.A 2009, 106:3348-3353.
8. Ebihara S., Shirato K., Harata N., Akaike N. Gramicidin-perforated patch recording: GABA response in mammalian neurones with intact intracellular chloride. J.Physiol. 1995, 484:77-86.
9. Kawahara M., Arispe N., Kuroda Y., Rojas E. Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. Biophys. J. 1997, 73:67-75.
10. Kayed R., Sokolov Y., Edmonds B., McIntire T.M., Milton S.C., Hall J.E., Glabe C.G. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J.Biol. Chem. 2004, 279:46363-46366.
11. Kelkar D.A., Chattopadhyay A. The gramicidin ion channel: a model membrane protein. Biochim. Biophys. Acta 2007, 1768:2011-2025.
12. Klunk W.E., Pettegrew J.W., Abraham D.J. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J.Histochem. Cytochem. 1989, 37:1273-1281.
13. Kourie J.I. Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases. Cell. Mol. Neurobiol. 2001, 21:173-213.
14. Kourie J.I., Henry C.L., Farrelly P. Diversity of amyloid beta protein fragment [1-40]-formed channels. Cell. Mol. Neurobiol. 2001, 21:255-284.
15. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993, 2:404-410.
16. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A 1985, 82:4245-4249.
17. Mezler M., Barghorn S., Schoemaker H., Gross G., Nimmrich V. Abeta-amyloid oligomer directly modulates P/Q-type calcium currents in Xenopus oocytes. Br. J. Pharmacol. 2012, 165:1572-1583.
18. Parodi J., Sepulveda F.J., Roa J., Opazo C., Inestrosa N.C., Aguayo L.G. Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J.Biol. Chem. 2010, 285:2506-2514.
19. Peters C., Fernandez-Perez E.J., Burgos C.F., Espinoza M.P., Castillo C., Urrutia J.C., Streltsov V.A., Opazo C., Aguayo L.G. Inhibition of amyloid beta-induced synaptotoxicity by a pentapeptide derived from the glycine zipper region of the neurotoxic peptide. Neurobiol. Aging 2013, 34:2805-2814.
20. Ronicke R., Mikhaylova M., Ronicke S., Meinhardt J., Schroder U.H., Fandrich M., Reiser G., Kreutz M.R., Reymann K.G. Early neuronal dysfunction by amyloid beta oligomers depends on activation of NR2B-containing NMDA receptors. Neurobiol. Aging 2011, 32:2219-2228.
21. Sepulveda F.J., Opazo C., Aguayo L.G. Alzheimer beta-amyloid blocks epileptiform activity in hippocampal neurons. Mol. Cell. Neurosci. 2009, 41:420-428.
22. Sepulveda F.J., Parodi J., Peoples R.W., Opazo C., Aguayo L.G. Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One 2010, 5:e11820.
23. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J.Neurosci. 2007, 27:2866-2875.
24. Soscia S.J., Kirby J.E., Washicosky K.J., Tucker S.M., Ingelsson M., Hyman B., Burton M.A., Goldstein L.E., Duong S., Tanzi R.E., Moir R.D. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 2010, 5:e9505.